Felix Stader
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- HIV/AIDS drug development and treatment 13
-
- Pharmacological Effects and Toxicity Studies 8
- Pharmaceutical studies and practices 4
- Co-authors
- Catia Marzolini (25 shared papers)Manuel Battegay (21 shared papers)Marco Siccardi (6 shared papers)Melissa A. Penny (5 shared papers)Laurent A. Décosterd (7 shared papers)Perrine Courlet (7 shared papers)Parham Sendi (2 shared papers)Iain Gardner (7 shared papers)
- Journals
- Clinical Pharmacokinetics (6 papers)Clinical Pharmacology & Therapeutics (4 papers)Pharmaceutics (3 papers)Open Forum Infectious Diseases (3 papers)CPT Pharmacometrics & Systems Pharmacology (3 papers)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
Felix Stader
31 papers receiving 449 citations
Peers
Comparison fields: 5 of 76
- Pharmacology 111
- Virology 60
- Infectious Diseases 175
- Geriatrics and Gerontology 32
- Emergency Medicine 77
Countries citing papers authored by Felix Stader
This map shows the geographic impact of Felix Stader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Stader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Stader more than expected).
Fields of papers citing papers by Felix Stader
This network shows the impact of papers produced by Felix Stader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Stader. The network helps show where Felix Stader may publish in the future.
Co-authors
The 25 scholars most cited alongside Felix Stader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 53 | |
| 2 | 2020 | 44 | |
| 3 | 2019 | 37 | |
| 4 | 2020 | 33 | |
| 5 | 2019 | 29 | |
| 6 | 2022 | 19 | |
| 7 | 2019 | 18 | |
| 8 | 2021 | 18 | |
| 9 | 2021 | 18 | |
| 10 | 2022 | 15 | |
| 11 | 2020 | 15 | |
| 12 | 2018 | 15 | |
| 13 | 2022 | 13 | |
| 14 | 2020 | 13 | |
| 15 | 2021 | 13 | |
| 16 | 2014 | 11 | |
| 17 | 2024 | 10 | |
| 18 | 2023 | 9 | |
| 19 | 2020 | 8 | |
| 20 | 2021 | 8 |
About Felix Stader
Felix Stader is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health, Molecular Biology, Emergency Medicine and Pharmacology, having authored 39 papers that have together received 455 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (13 papers), Pharmacogenetics and Drug Metabolism (9 papers), Pharmacological Effects and Toxicity Studies (8 papers), HIV-related health complications and treatments (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Drug Transport and Resistance Mechanisms (5 papers), HIV Research and Treatment (4 papers) and Pharmaceutical studies and practices (4 papers). The work is most often cited by research in Pharmacology (111 citations), Virology (60 citations), Infectious Diseases (175 citations), Geriatrics and Gerontology (32 citations) and Emergency Medicine (77 citations). Felix Stader has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Catia Marzolini, Manuel Battegay, Marco Siccardi, Melissa A. Penny, Laurent A. Décosterd, Perrine Courlet, Parham Sendi, Iain Gardner, Masoud Jamei and Katherine L. Gill. Their work appears in journals such as Clinical Pharmacokinetics, Clinical Pharmacology & Therapeutics, Pharmaceutics, Open Forum Infectious Diseases and CPT Pharmacometrics & Systems Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.